Lumenis Ltd., the world’s largest energy-based medical device company for ophthalmic, aesthetic and surgical applications and the inventor of intense pulsed light (IPL) technology, today announced that the FDA has granted De Novo authorization for Lumenis’ newest IPL device for improving signs of dry eye disease due to meibomian gland dysfunction (MGD).
Significantly Improved Signs of Dry Eye Disease: Key Findings from FDA Study of Lumenis Light Therapy
The strongest affirmation of safety and efficacy- Dr. Steven Dell shares clinical benefits of Lumenis dry eye light therapy that…
Configurations
Versatile platform for those focused on practice growth, enables a customized approach across the broadest range of patients and treatment areas Vacuum Assisted High-Speed Integrated Technology A large 22×35 mm spot size enables the use of low-fluence and with a unique mechanism for pain reduction provides effective, fast and comfortable treatment. ChillTip™ Technology – Integrated contact cooling provides epidermal protection for treatment areas requiring precision and higher fluence
Digital Trio
The Digital Trio reimagines laser therapy with the first digital dual path SLT-YAG platform on the market. The Digital Trio configuration adds a state-of-the-art retinal care photocoagulator to the digital dual path SLT-YAG system.
Clinical Results
The LightSheer technology by Lumenis has been validated in numerous clinical studies and peer reviewed articles. Our customers benefit from the LightSheer DESIRE features and enjoy high patient satisfaction.
How will your patients benefit?
Patient Benefits: Faster Treatment Time Ultimate Patient Comfort Clinically Validated Efficacy
The Ultimate Guide to OptiLight for Dry Eye
Hear from two prominent dry eye specialists in the Ultimate Guide to OptiLight for Dry Eye and learn about how they incorporated OptiLight into the practice, access comprehensive information on the history of IPL technology, and gain clear understanding on the unique benefits of OptiLight. The guide includes clinical data on how OptiLight can improve meibomian gland dysfunction through several mechanisms of action, along with pre and post treatment care and quick tips for performing the procedure. This ultimate guide provides scripts for easy ways to talk to patients about OptiLight and valuable recommendations from experts who have leveraged OptiLight to provide a real solution to their patients and elevate their practice success.
Transform Dry Eye Management with the Lumenis Portfolio
Dr. Lori Duquette’s personal struggle with dry eye inspired her to search for better solutions. By bringing OptiLIGHT IPL, OptiPLUS RF, and OptiLIFT DMSt into her practice, she now delivers more personalized treatments that benefit both her and her patients. She shares her approach to dry eye management and her advice for other doctors looking to invest in in-office technologies.
Thomas Nido’s OptiLIGHT Treatment Journey Unveiled!
Embark on a remarkable journey with Tomas as he shares his experience with OptiLIGHT treatment for his dry eyes. With each session lasting just 15 minutes with minimal downtime, OptiLIGHT by Lumenis has empowered Tomas to confront his dry eyes head-on.
Kerri Walsh Jennings Shares the Impact of OptiLIGHT Treatment on Her Dry Eye Disease!
Kerri Walsh Jennings Shares the Impact of OptiLIGHT Treatment on Her Dry Eye Disease!